Trading
Please use a PC Browser to access Register-Tadawul
Seeing Reports Novo Nordisk Names Maziar Mike Doustdar As New CEO
Share
Novo Nordisk A/S Sponsored ADR Class B
NVO
48.96
47.96
-2.80%